Differentiating bipolar disorders from major depressive disorders: Treatment implications

Annals of Clinical Psychiatry

Volumn 19, Issue 4, 2007, Pages 305-312

  Muzina, David J ^a   Kemp, David E ^b   McIntyre, Roger S ^c,d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Antidepressants; Bipolar disorder; Major depressive disorder; Treatment

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; DESIPRAMINE; FLUOXETINE PLUS OLANZAPINE; LAMOTRIGINE; LITHIUM; PAROXETINE; PLACEBO; QUETIAPINE; VALPROIC ACID; VENLAFAXINE;

ARTICLE; BIPOLAR DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMAN; HYPOMANIA; MAJOR DEPRESSION; MEDLINE; MOOD CHANGE; PRIORITY JOURNAL; SCREENING; SIDE EFFECT;

ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC ERRORS; HUMANS; PREVALENCE;

EID: 36749050920     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: 10.1080/10401230701653591     Document Type: Article

References (64)

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. Jun 2005; 62:593-602
2. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: Re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord. Jan 2003; 73:123-131
3. Calabrese JR, Hirschfeld RM, Frye MA, Reed ML. Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample. J Clin Psychiatry. Nov 2004; 65:1499-1504
4. Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H, Hirschfeld R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord. Sep 2000; 59(Suppl 1):S5-S30
5. Hirschfeld RM. Bipolar spectrum disorder: Improving its recognition and diagnosis. J Clin Psychiatry. 2001; 62(Suppl 14):5-9
6. Hirschfeld RM, Calabrese JR, Weissman MM, Reed M, Davies MA, Frye MA, Keck PE Jr, Lewis L, McElroy SL, McNulty JP, Wagner KD.. Screening for bipolar disorder in the community. J Clin Psychiatry. Jan 2003; 64:53-59
7. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry. Jan 2003; 160:4-12
8. Lenox RH, Gould TD, Manji HK. Endophenotypes in bipolar disorder. Am J Med Genet. May 8 2002; 114:391-406
9. Akiskal HS, Hantouche EG, Bourgeois ML, Azorin JM, Sechter D, Allilaire JF, Lancrenon S, Fraud JP, Châtenet-Duchêne L. Gender, temperament, and the clinical picture in dysphoric mixed mania: Findings from a French national study (EPIMAN). J Affect Disord. Sep 1998; 50:175-186
10. Goldberg JF, Harrow M, Whiteside JE. Risk for bipolar illness in patients initially hospitalized for unipolar depression. Am J Psychiatry. Aug 2001; 158:1265-1270
11. Hantouche EG, Angst J, Akiskal HS. Factor structure of hypomania: Interrelationships with cyclothymia and the soft bipolar spectrum. J Affect Disord. Jan 2003; 73:39-47
12. Perlis RH, Brown E, Baker RW, Nierenberg AA. Clinical features of bipolar depression versus major depressive disorder in large multicenter trials. Am J Psychiatry. Feb 2006; 163:225-231
13. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: A controversy revisited. Am J Psychiatry. Aug 1995; 152:1130-1138
14. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry. Nov 1987; 144:1403-1411
15. Kraepelin E. Manic-depressive insanity and paranoia. Edinburgh: Livingstone E & S; 1921
16. Angst J, Merikangas KR. The depressive spectrum: Diagnostic classification and course. J Affect Disord. 1997; 45:31-40
17. Perris C. A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. Acta Psychiatr Scand Suppl. 1966; 194:9-14
18. Angst J, Marneros A. Bipolarity from ancient to modern times: Conception, birth and rebirth. J Affect Disord. Dec 2001; 67:3-19
19. Suppes T, Leverich GS, Keck PE, Nolen WA, Denicoff KD, Altshuler LL, McElroy SL, Rush AJ, Kupka R, Frye MA, Bickel M, Post RM.. The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord. Dec 2001; 67:45-59
20. Judd LL, Schettler PJ, Akiskal HS, Maser J, Coryell W, Solomon D, Endicott J, Keller M.. Long-term symptomatic status of bipolar I vs. bipolar II disorders. Int J Neuropsychopharmacol. Jun 2003;6:127-137
21. Frye MA, Calabrese JR, Reed ML, Hirschfeld RM. Healthcare resource utilization in bipolar depression compared with unipolar depression: Results of a United States population-based study. CNS Spectr. Sep 2006;11:704-710; quiz 719.
22. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord. Aug 1994; 31:281-294
23. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: How far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. Feb 2003; 64:161-174
24. Access Economics fSA. Bipolar disorder: Costs. An analysis of the burden of bipolar disorder and related suicide in Australia; 2003; Melbourne: Access Economics, for SANE Australia. Available: www.accesseconomics.com.au/reports/41. pdf
25. Hirschfeld RM, Cass AR, Holt DC, Carlson CA. Screening for bipolar disorder in patients treated for depression in a family medicine clinic. J Am Board Fam Pract. Jul-Aug 2005; 18:233-239
26. Calabrese JR, Muzina DJ, Kemp DE, Sachs GS, Frye MA, Thompson TR, Klingman D, Reed ML, Hirschfeld RM. Predictors of bipolar disorder risk among patients currently treated for major depression. Med Gen Medi 2006; 8:38.
27. Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE Jr, Lewis L, McElroy SL, Post RM, Rapport DJ, Russell JM, Sachs GS, Zajecka J.. Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire. Am J Psychiatry. Nov 2000; 157:1873-1875
28. Wagner KD, Hirschfeld RM, Emslie GJ, Findling RL, Gracious BL, Reed ML. Validation of the Mood Disorder Questionnaire for bipolar disorders in adolescents. J Clin Psychiatry. May 2006; 67:827-830
29. Ghaemi SN, Miller CJ, Berv DA, Klugman J, Rosenquist KJ, Pies RW. Sensitivity and specificity of a new bipolar spectrum diagnostic scale. J Affect Disord. Feb 2005; 84:273-277
30. Miller CJ, Klugman J, Berv DA, Rosenquist KJ, Ghaemi SN. Sensitivity and specificity of the Mood Disorder Questionnaire for detecting bipolar disorder. J Affect Disord. Aug 2004; 81:167-171
31. Angst J, Adolfsson R, Benazzi F. The HCL-32: Towards a selfassessment tool for hypomanic symptoms in outpatients. J Affect Disord. 2005; 88:167-171
32. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lépine JP, Newman SC, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen H, Yeh EK. Cross-national epidemiology of major depression and bipolar disorder. Jama. Jul 24-31 1996; 276:293-299
33. Manning JS, Connor PD, Sahai A. The bipolar spectrum: A review of current concepts and implications for the management of depression in primary care. Arch Fam Med. Jan-Feb 1998; 7:63-71
34. Heun R, Maier W. The distinction of bipolar II disorder from bipolar I and recurrent unipolar depression: Results of a controlled family study. Acta Psychiatr Scand. Apr 1993; 87:279-284
35. Joyce PR, Doughty CJ, Wells JE, Walsh AE, Admiraal A, Lill M, Olds RJ. Affective disorders in the first-degree relatives of bipolar probands: Results from the South Island Bipolar Study. Compr Psychiatry. May-Jun 2004; 45:168-174
36. McIntyre RS, Konarski JZ, Soczynska JK, Wilkins K, Panjwani G, Bouffard B, Bottas A, Kennedy SH. Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. Psychiatr Serv. Aug 2006; 57:1140-1144
37. Osby U, Brandt L, Correia N, Ekbom A, Sparen P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. Sep 2001; 58:844-850
38. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. Jama. Nov 21 1990; 264:2511-2518
39. Ghaemi SN, Rosenquist KJ, Ko JY, Baldassano CF, Kontos NJ, Baldessarini RJ. Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry. Jan 2004; 161:163-165
40. Brockington IF, Altman E, Hillier V, Meltzer HY, Nand S. The clinical picture of bipolar affective disorder in its depressed phase. A report from London and Chicago. Br J Psychiatry. Dec 1982; 141:558-562
41. Detre T, Himmelhoch J, Swartzburg M, Anderson CM, Byck R, Kupfer DJ. Hypersomnia and manic-depressive disease. Am J Psychiatry. Apr 1972; 128:1303-1305
42. Perugi G, Akiskal HS, Lattanzi L, Cecconi D, Mastrocinque C, Patronelli A, Vignoli S, Bemi E. The high prevalence of "soft" bipolar (II) features in atypical depression. Compr Psychiatry. Mar-Apr 1998; 39:63-71
43. Benazzi F. Bipolar disorder - focus on bipolar II disorder and mixed depression. Lancet. Mar 17 2007; 369(9565):935-945
44. Benazzi F. Family history validation of a definition of mixed depression. Compr Psychiatry. May-Jun 2005; 46:159-166
45. Sato T, Bottlender R, Schroter A, Moller HJ. Frequency of manic symptoms during a depressive episode and unipolar 'depressive mixed state' as bipolar spectrum. Acta Psychiatr Scand. Apr 2003; 107:268-274
46. Hantouche EG, Akiskal HS. Bipolar II vs. unipolar depression: psychopathologic differentiation by dimensional measures. J Affect Disord. Feb 2005; 84:127-132
47. Suppes T, Dennehy EB, Hirschfeld RM, Altshuler LL, Bowden CL, Calabrese JR, Crismon ML, Ketter TA, Sachs GS, Swann AC; Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder. The Texas implementation of medication algorithms: Update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry. Jul 2005; 66:870-886
48. Yatham LN, Kennedy SH, O'Donovan C, Parikh SV, MacQueen G, McIntyre RS, Sharma V, Beaulieu S; Guidelines Group, CANMAT. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: Update 2007. Bipolar Disord. Dec 2006; 8:721-739
49. Yatham LN, Kennedy SH, O'Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, Silverstone P, Alda M, Baruch P, Beaulieu S, Daigneault A, Milev R, Young LT, Ravindran A, Schaffer A, Connolly M, Gorman CP; Canadian Network for Mood and Anxiety Treatments. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: Consensus and controversies. Bipolar Disord. 2005; 7(Suppl 3):5-69
50. Goodwin GM, Young AH. The British Association for Psychopharmacology guidelines for treatment of bipolar disorder: A summary. J Psychopharmacol. Dec 2003; 17(4 Suppl):3-6
51. Hirschfeld R. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. Apr 2002; 159(Suppl):1-50
52. Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P, Rapport D, Martinez JM, Allen MH, Miklowitz DJ, Otto MW, Dennehy EB, Thase ME. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. Apr 26 2007; 356:1711-1722
53. Calabrese JR, Keck PE, Jr., Macfadden W, Minkwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoy R, Wilson E, Mullen J. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry. Jul 2005; 162:1351-1360
54. Thase ME, Macfadden W, Weisler RH, Chang W, Paulsson B, Khan A, Calabrese JR; BOLDER II Study Group. Efficacy of quetiapine monotherapy in bipolar I and II depression: a doubleblind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol. Dec 2006; 26:600-609
55. Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry. Nov 2003; 60:1079-1088
56. Boerlin HL, Gitlin MJ, Zoellner LA, Hammen CL. Bipolar depression and antidepressant-induced mania: A naturalistic study. J Clin Psychiatry. Jul 1998; 59:374-379
57. Post RM, Altshuler LL, Frye MA, Suppes T, McElroy S, Keck PE Jr, Leverich GS, Kupka R, Nolen WA, Grunze H. New findings from the Bipolar Collaborative Network: Clinical implications for therapeutics. Curr Psychiatry Rep. Dec 2006; 8:489-497
58. Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Kupka RW, Denicoff KD, Nolen WA, Grunze H, Martinez MI, Post RM. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry. Feb 2006; 163:232-239
59. Goldberg JF, Truman CJ. Antidepressant-induced mania: an overview of current controversies. Bipolar Disord. Dec 2003; 5:407-420
60. Altshuler LL, Suppes T, Black DO, Nolen WA, Leverich G, Keck PE Jr, Frye MA, Kupka R, McElroy SL, Grunze H, Kitchen CM, Post R. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. Am J Psychiatry. Feb 2006; 163:313-315
61. Shin K, Schaffer A, Levitt AJ, Boyle MH. Seasonality in a community sample of bipolar, unipolar and control subjects. J Affect Disord. May 2005; 86:19-25
62. Freeman MP, Gelenberg AJ. Bipolar disorder in women: Reproductive events and treatment considerations. Acta Psychiatr Scand. Aug 2005; 112:88-96
63. Thase ME. Bipolar depression: Diagnostic and treatment considerations. Dev Psychopathol. Fall 2006; 18:1213-1230
64. McIntyre RS, Konarski JZ, Wilkins K, Bouffard B, Soczynska JK, Kennedy SH. The prevalence and impact of migraine headache in bipolar disorder: Results from the Canadian Community Health Survey. Headache. Jun 2006; 46:973-982